We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
BridgeBio Pharma Inc | NASDAQ:BBIO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 29.28 | 27.10 | 31.45 | 0 | 09:00:01 |
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
||
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
Item 1.01. |
Entry into a Material Definitive Agreement
|
BridgeBio Pharma, Inc.
|
|||
Date:
|
March 4, 2024
|
By:
|
/s/ Brian C. Stephenson
|
Brian C. Stephenson
|
|||
Chief Financial Officer
|
Document and Entity Information |
Mar. 01, 2024 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Mar. 01, 2024 |
Entity File Number | 001-38959 |
Entity Registrant Name | BridgeBio Pharma, Inc. |
Entity Central Index Key | 0001743881 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 84-1850815 |
Entity Address, Address Line One | 3160 Porter Dr. |
Entity Address, Address Line Two | Suite 250 |
Entity Address, City or Town | Palo Alto |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94304 |
City Area Code | 650 |
Local Phone Number | 391-9740 |
Title of 12(b) Security | Common Stock, par value $0.001 per share |
Trading Symbol | BBIO |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
1 Year BridgeBio Pharma Chart |
1 Month BridgeBio Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions